These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32921792)

  • 21. NKTR-102 Efficacy versus irinotecan in a mouse model of brain metastases of breast cancer.
    Adkins CE; Nounou MI; Hye T; Mohammad AS; Terrell-Hall T; Mohan NK; Eldon MA; Hoch U; Lockman PR
    BMC Cancer; 2015 Oct; 15():685. PubMed ID: 26463521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noscapine crosses the blood-brain barrier and inhibits glioblastoma growth.
    Landen JW; Hau V; Wang M; Davis T; Ciliax B; Wainer BH; Van Meir EG; Glass JD; Joshi HC; Archer DR
    Clin Cancer Res; 2004 Aug; 10(15):5187-201. PubMed ID: 15297423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional imaging of multidrug resistance in an orthotopic model of osteosarcoma using 99mTc-sestamibi.
    Gomes CM; Welling M; Que I; Henriquez NV; van der Pluijm G; Romeo S; Abrunhosa AJ; Botelho MF; Hogendoorn PC; Pauwels EK; Cleton-Jansen AM
    Eur J Nucl Med Mol Imaging; 2007 Nov; 34(11):1793-803. PubMed ID: 17541583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of B7 co-stimulatory molecules by B16 melanoma results in a natural killer cell-dependent local anti-tumour response, but induces T-cell-dependent systemic immunity only against B7-expressing tumours.
    Chong H; Hutchinson G; Hart IR; Vile RG
    Br J Cancer; 1998 Oct; 78(8):1043-50. PubMed ID: 9792148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human bone marrow-derived stromal cell behavior when injected directly into the bone marrow of NOD-scid-gamma mice pre-conditioned with sub-lethal irradiation.
    Nowlan B; Futrega K; Williams ED; Doran MR
    Stem Cell Res Ther; 2021 Apr; 12(1):231. PubMed ID: 33845908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multimodality imaging and preclinical evaluation of 177Lu-AMBA for human prostate tumours in a murine model.
    Liu IH; Chang CH; Ho CL; Chiu SP; Lee WC; Chang TJ; Chen LC; Wu YH; Chuang CH; Fu YK; Lee TW
    Anticancer Res; 2010 Oct; 30(10):4039-48. PubMed ID: 21036718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of autoreactive T and B lymphocytes by anti-annexin A1 antibody in a humanized NSG murine model of systemic lupus erythematosus.
    Mihaylova N; Chipinski P; Bradyanova S; Velikova T; Ivanova-Todorova E; Chausheva S; Herbáth M; Kalinova D; Prechl J; Kyurkchiev D; Tchorbanov AI
    Clin Exp Immunol; 2020 Mar; 199(3):278-293. PubMed ID: 31724735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imaging of luciferase and GFP-transfected human tumours in nude mice.
    Caceres G; Zhu XY; Jiao JA; Zankina R; Aller A; Andreotti P
    Luminescence; 2003; 18(4):218-23. PubMed ID: 12950058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The dual effect of mesenchymal stem cells on tumour growth and tumour angiogenesis.
    Kéramidas M; de Fraipont F; Karageorgis A; Moisan A; Persoons V; Richard MJ; Coll JL; Rome C
    Stem Cell Res Ther; 2013 Apr; 4(2):41. PubMed ID: 23628074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-tumour efficacy on glioma models of PHA-848125, a multi-kinase inhibitor able to cross the blood-brain barrier.
    Albanese C; Alzani R; Amboldi N; Degrassi A; Festuccia C; Fiorentini F; Gravina G; Mercurio C; Pastori W; Brasca M; Pesenti E; Galvani A; Ciomei M
    Br J Pharmacol; 2013 May; 169(1):156-66. PubMed ID: 23347136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of [
    Vermeulen K; Naus E; Ahamed M; Attili B; Siemons M; Luyten K; Celen S; Schymkowitz J; Rousseau F; Bormans G
    Theranostics; 2019; 9(2):554-572. PubMed ID: 30809293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen protects the blood-brain barrier from inflammation-induced disruption and increased lymphocyte trafficking.
    Maggioli E; McArthur S; Mauro C; Kieswich J; Kusters DHM; Reutelingsperger CPM; Yaqoob M; Solito E
    Brain Behav Immun; 2016 Jan; 51():212-222. PubMed ID: 26321046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glioma targeting peptide modified apoferritin nanocage.
    Zhai M; Wang Y; Zhang L; Liang M; Fu S; Cui L; Yang M; Gong W; Li Z; Yu L; Xie X; Yang C; Yang Y; Gao C
    Drug Deliv; 2018 Nov; 25(1):1013-1024. PubMed ID: 29726297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation on the effect of nanoparticle size on the blood-brain tumour barrier permeability by in situ perfusion via internal carotid artery in mice.
    Kang JH; Cho J; Ko YT
    J Drug Target; 2019 Jan; 27(1):103-110. PubMed ID: 29972326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel anti-inflammatory mechanism of high density lipoprotein through up-regulating annexin A1 in vascular endothelial cells.
    Pan B; Kong J; Jin J; Kong J; He Y; Dong S; Ji L; Liu D; He D; Kong L; Jin DK; Willard B; Pennathur S; Zheng L
    Biochim Biophys Acta; 2016 Jun; 1861(6):501-12. PubMed ID: 27012521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-1 receptor antagonist inhibits subcutaneous B16 melanoma growth in vivo.
    McKenzie RC; Oran A; Dinarello CA; Sauder DN
    Anticancer Res; 1996; 16(1):437-41. PubMed ID: 8615650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of luciferase tagged brain tumour models in mice for chemotherapy intervention studies.
    Kemper EM; Leenders W; Küsters B; Lyons S; Buckle T; Heerschap A; Boogerd W; Beijnen JH; van Tellingen O
    Eur J Cancer; 2006 Dec; 42(18):3294-303. PubMed ID: 17027258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel chalcone derivative which acts as a microtubule depolymerising agent and an inhibitor of P-gp and BCRP in in-vitro and in-vivo glioblastoma models.
    Boumendjel A; McLeer-Florin A; Champelovier P; Allegro D; Muhammad D; Souard F; Derouazi M; Peyrot V; Toussaint B; Boutonnat J
    BMC Cancer; 2009 Jul; 9():242. PubMed ID: 19619277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of pro-invasive mechanisms and N-terminal cleavage of ANXA1 in melanoma.
    Boudhraa Z; Merle C; Mazzocut D; Chezal JM; Chambon C; Miot-Noirault E; Theisen M; Bouchon B; Degoul F
    Arch Dermatol Res; 2014 Dec; 306(10):903-14. PubMed ID: 25362540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PTK787/ZK222584, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor, reduces uptake of the contrast agent GdDOTA by murine orthotopic B16/BL6 melanoma tumours and inhibits their growth in vivo.
    Rudin M; McSheehy PM; Allegrini PR; Rausch M; Baumann D; Becquet M; Brecht K; Brueggen J; Ferretti S; Schaeffer F; Schnell C; Wood J
    NMR Biomed; 2005 Aug; 18(5):308-21. PubMed ID: 15918178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.